Mechanism of Bispecific Antibodies and Clinical Research Advances in Lung Cancer.

Yang J, Liang Y, Zhu M, Meng Y, Wang X, Yu M, Li L, Kong F.

Open source

DOI
10.2174/0115680096353819250127065001
Published
2026-01-01
Container
Curr Cancer Drug Targets
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0115680096353819250127065001,
  title = {Mechanism of Bispecific Antibodies and Clinical Research Advances in Lung Cancer.},
  author = {Yang J and  Liang Y and  Zhu M and  Meng Y and  Wang X and  Yu M and  Li L and  Kong F.},
  year = {2026},
  journal = {Curr Cancer Drug Targets},
  doi = {10.2174/0115680096353819250127065001},
  url = {https://doi.org/10.2174/0115680096353819250127065001}
}

RIS

TY  - JOUR
TI  - Mechanism of Bispecific Antibodies and Clinical Research Advances in Lung Cancer.
AU  - Yang J
AU  -  Liang Y
AU  -  Zhu M
AU  -  Meng Y
AU  -  Wang X
AU  -  Yu M
AU  -  Li L
AU  -  Kong F.
PY  - 2026
JO  - Curr Cancer Drug Targets
DO  - 10.2174/0115680096353819250127065001
UR  - https://doi.org/10.2174/0115680096353819250127065001
ER  - 

APA

J, Y., Y, L., M, Z., Y, M., X, W., M, Y., L, L., & F., K. (2026). Mechanism of Bispecific Antibodies and Clinical Research Advances in Lung Cancer.. Curr Cancer Drug Targets. https://doi.org/10.2174/0115680096353819250127065001

Source records